|
|
|
|
Medical News: Amneal Receives FDA Approval For Tramadol/APAP Tablets
Amneal Pharmaceuticals is pleased to announce that it received U.S.FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December 9, 2009. Amneal's generic is...
|
|
|
Amneal Receives FDA Approval For Tramadol/APAP Tablets
Amneal Pharmaceuticals is pleased to announce that it received U.S.FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December 9, 2009. Amneal's generic is...
|
|
|
2/9/10 - Amneal Pharmaceuticals wins FDA approval for pain drug
(Datamonitor via COMTEX) Amneal Pharmaceuticals, a developer of generic pharmaceuticals, has received the FDA's approval to manufacture combination tramadol HCl in 37.5mg strength and acetaminophen in 325mg strength in tablet form.Amneal's generic is an AB...
|
|
|
Centocor Ortho Biotech Inc.-Company Report - new market report released
Refer to a friend 2010-02-09 09:58:16 - Centocor Ortho Biotech Inc.-Company Report - a new market research report on companiesandmarkets.com Centocor Ortho Biotech Inc.-Company Report is a private Company Report that provides up to date insight into...
|
|
|
Awards for West Midlands medtech companies
International demand for infection control solutions and cost-effective manufacturing tools has helped five groundbreaking businesses from the UK West Midlands win awards in the Medical and Healthcare Business Awards 2010, organised by MedilinkWM.Shining the...
|
|
|
Amneal Pharmaceuticals wins FDA approval for pain drug
(Datamonitor via COMTEX) Amneal Pharmaceuticals, a developer of generic pharmaceuticals, has received the FDA's approval to manufacture combination tramadol HCl in 37.5mg strength and acetaminophen in 325mg strength in tablet form.Amneal's generic is an AB...
|
|
|
Prezista Now Approved as Part of Combination Therapy for Pediatric Patients Six Years of Age and Older with HI
PREZISTA* Now Approved as Part of Combination Therapy for Pediatric Patients Six Years of Age and Older with HIV Approval based on DELPHI study that demonstrated 74 per cent of pediatric patients taking PREZISTA in combination with other antiretrovirals had at...
|
|
|
PREZISTA(R)* Now Approved as Part of Combination Therapy for Pediatric Patients Six Years of Age and Older with HIV
- Approval based on DELPHI study that demonstrated 74 per cent of pediatric patients taking PREZISTA(R) in combination with other antiretrovirals had at least a 90 per cent reduction in viral loads at 24 weeks - Tibotec, a division of Janssen-Ortho Inc.
|
|
|
Amneal receives FDA approval for generic painkiller
HAUPPAUGE,N.Y.(Feb. 8) Amneal Pharmaceuticals has received approval from the Food and Drug Administration to manufacture a generic version of a painkiller made by Johnson & Johnson, the generic drug maker announced Monday. Amneal said the FDA had...
|
|
|
FDA approves Amneal Pharmaceuticals' Tramadol/APAP tablets
Amneal Pharmaceuticals is pleased to announce that it received U.S.FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December 9, 2009. Amneals generic is...
|
|
|
2/8/10 - Amneal Receives FDA Approval for Tramadol/APAP Tablets
HAUPPAUGE, N.Y.(BUSINESS WIRE) Amneal Pharmaceuticals is pleased to announce that it received U.S.FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December...
|
|
|
Golimumab shows robust effect for inhibiting arthritic joint damage
Study finds golimumab, like other anti-TNF-alpha agents, inhibits structural damage in rheumatic diseases Radiologic data may underscore for rheumatologists and dermatologists the importance of ensuring patients with psoriatic arthritis receive early and...
|
|
|
Amneal Receives FDA Approval for Tramadol/APAP Tablets
HAUPPAUGE, N.Y.(BUSINESS WIRE) Amneal Pharmaceuticals is pleased to announce that it received U.S.FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December...
|
|
|
Amneal Receives FDA Approval for Tramadol/APAP Tablets
- Amneal Pharmaceuticals is pleased to announce that it received U.S.FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December 9, 2009. Amneal's generic...
|
|
|
Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equity
DALLAS, Feb.8, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Arena Pharmaceuticals Incorporated (Nasdaq:ARNA - News). The report includes financial, comparative and investment analyses, and industry information you need...
|
|
|
Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equity
(GlobeNewswire via COMTEX) ----BeaconEquity.com announces an investment report featuring Arena Pharmaceuticals Incorporated (Nasdaq:ARNA).The report includes financial, comparative and investment analyses, and industry information you need to know to make an...
|
|
|
Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equity
DALLAS, Feb.8, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Arena Pharmaceuticals Incorporated (Nasdaq:ARNA - News). The report includes financial, comparative and investment analyses, and industry information you need...
|
|
|
Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon
DALLAS, Feb.8, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Arena Pharmaceuticals Incorporated (Nasdaq:ARNA). The report includes financial, comparative and investment analyses, and industry information you need to...
|
|
|
Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equity
DALLAS, Feb.8, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Arena Pharmaceuticals Incorporated (Nasdaq: ARNA). The report includes financial, comparative and investment analyses, and industry information you need to...
|
|
|
Alkermes Reports Third Quarter Fiscal 2010 Financial Results
Record Sales of RISPERDAL CONSTA Company Expands Proprietary Pipeline to Include Long-Acting Versions of Two Blockbuster Medications WALTHAM, Mass.--(BUSINESS WIRE)--Feb 4, 2010 - Alkermes, Inc.(NASDAQ: ALKS) today reported financial results for its third...
|
|
|
Family blames birth control patch
Taipei City Councilor Huang Hsiang-chun, left, listens as the elder sister of a woman who fell into a coma after allegedly taking a birth control patch produced by a multinational company warned the public about the products possible side-effects.PHOTO: CNA...
|
|
|
OrthoCor to launch knee system by mid-March
OrthoCor Medical is preparing to introduce by the middle of next month its Ortho OrthoCor to launch knee system by mid-March.
|
|
|
Questcor Pharmaceuticals appoints new chief medical officer - Zib...
Company: Questcor Pharmaceuticals, Inc.(QCOR) Questcor Pharmaceuticals, a provider of prescription drugs for the treatment of rare central nervous system and inflammatory disorders, has appointed Jason Zielonkaas its new chief medical officer. Dr Zielonka...
|
|
|
Questcor Pharmaceuticals appoints new chief medical officer
Questcor Pharmaceuticals, a provider of prescription drugs for the treatment of rare central nervous system and inflammatory disorders, has appointed Jason Zielonkaas its new chief medical officer.Dr Zielonka has accepted the company's offer to become chief...
|
|
|
Questcor Pharmaceuticals appoints new chief medical officer
Questcor Pharmaceuticals, a provider of prescription drugs for the treatment of rare central nervous system and inflammatory disorders, has appointed Jason Zielonkaas its new chief medical officer.Dr Zielonka has accepted the company's offer to become chief...
|
